<!DOCTYPE html>
<html lang="en-US"><head>
		<meta charset="UTF-8">
		<title>FR941003-2-00035</title>
	</head>
	<body>
		<main>
			<p><!-- PJG STAG 4703 -->  <!-- PJG ITAG l=94 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=69 g=1 f=1 -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=50 g=1 f=1 -->   <USDEPT>DEPARTMENT OF HEALTH AND HUMAN SERVICES</USDEPT>  <!-- PJG /ITAG -->  <!-- PJG ITAG l=18 g=1 f=1 -->  <USBUREAU>Office of the Secretary</USBUREAU> <!-- PJG 0012 frnewline -->  <USBUREAU>Office of the General Counsel and Public Health Service</USBUREAU> <USBUREAU>Food and Drug Administration</USBUREAU> <!-- PJG /ITAG -->  <!-- PJG ITAG l=55 g=1 f=1 --> Statement of Organization, Functions, and Delegations of Authority <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Part A, Chapter AG (Office of the General Counsel) (38 FR 17032, June 28, 1973, as amended most recently at 57 FR 10765, March 30, 1992) and Part H, Chapter HF (Food and Drug Administration) 35 FR 3685, February 25, 1970, as amended most recently at 59 FR 38482, July 28, 1994) of the Statement of Organization, Functions, and Delegations of Authority for the Department of Health and Human Services is amended to reflect an organizational change in the Office of the General Counsel (OGC) and in the Food and Drug Administration (FDA). <!-- PJG 0012 frnewline --> The OGC in the Office of the Secretary, HHS, and FDA find it in their common interest and interest of the Department to test the efficacy of decentralizing the provision of legal services to FDA by establishing an organizational component within FDA comprised of lawyers and support staff who will provide certain legal services exclusively to that Agency and be funded by that Agency, but be subject to the supervision of the General Counsel with respect to legal policy and direction. OGC will continue to provide legal services to FDA in the areas of ethics, business and administrative law, legislation, personnel, and procurement on the same basis as OGC provides such services to other HHS operating divisions generally. A new Office of the Chief Counsel will be established in FDAs Office of the Commissioner and simultaneously the Food and Drug Division will be removed from OGC. <!-- PJG 0012 frnewline --> The following changes are made to reflect the organizational change: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=87 g=1 f=1 --> Under Chapter AG, Section AG&hyph;B, Organization <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 1. Under Section AG.22 Divisions in the Office of the General Counsel delete subparagraph 4 Food and Drug Division in its entirety. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=87 g=1 f=1 --> Under Chapter HF, Section HF&hyph;B, Organization <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> 2. Insert a new subparagraph under the Office of the Commissioner (HF), the Office of Chief Counsel (HFA&hyph;J) reading as follows: <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=3 --> (a&hyph;6) Office of Chief Counsel (HFA&hyph;J).  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 --> Subject to the professional supervision and control of the General Counsel, represents the FDA in court proceedings and administrative hearings with respect to programs administered by the FDA. <!-- PJG 0012 frnewline --> Provides legal advice and policy guidance for programs administered by the FDA. <!-- PJG 0012 frnewline --> Acts as liaison to the Department of Justice and other Federal Departments for programs administered by FDA. <!-- PJG 0012 frnewline --> Drafts or reviews all proposed and final regulations and  <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=4 --> Federal Register <!-- PJG /ITAG -->  <!-- PJG ITAG l=11 g=1 f=1 -->  notices prepared by FDA. <!-- PJG 0012 frnewline --> Performs legal research and gives legal opinions on regulatory issues, actions, and petitions submitted to FDA. <!-- PJG 0012 frnewline --> Reviews proposed legislation affecting FDA that originates in the Department or on which Congress requests the views of the Department. <!-- PJG 0012 frnewline --> Provides legal advice and assistance to the Office of the Secretary on matters within the expertise of the Chief Counsel. <!-- PJG /ITAG -->  <!-- PJG QTAG 04 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Dated: September 17, 1994. <!-- PJG /ITAG -->  <!-- PJG QTAG 02 --> <!-- PJG /QTAG -->  <!-- PJG 0012 frnewline -->  <!-- PJG ITAG l=21 g=1 f=1 --> Effective Date: October 1, 1994. <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG -->  <SIGNER> <!-- PJG ITAG l=06 g=1 f=1 --> Donna E. Shalala, <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNER> <SIGNJOB> <!-- PJG ITAG l=04 g=1 f=1 --> Secretary. <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </SIGNJOB> <FRFILING> <!-- PJG ITAG l=40 g=1 f=1 --> [FR Doc. 94&hyph;24216 Filed 9&hyph;30&hyph;94; 8:45 am] <!-- PJG 0012 frnewline -->  <!-- PJG 0012 frnewline -->  <!-- PJG /ITAG --> </FRFILING> <BILLING> <!-- PJG ITAG l=68 g=1 f=1 --> BILLING CODE 4160&hyph;1&hyph;M <!-- PJG /ITAG --> </BILLING>  <!-- PJG 0012 frnewline -->  <!-- PJG /STAG --></p>
		</main>
</body></html>
            